Molecule Details
InChIKeyKQKPFRSPSRPDEB-UHFFFAOYSA-N
Compound NameSumatriptan
Canonical SMILESCNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)9
Pfam Stratification Cross-Family
Avg pChEMBL7.23
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00669
Drug NameSumatriptan
CAS Number103628-46-2
Groups approved investigational
ATC Codes N02CC01 G01AE10 N02CC51
DescriptionSumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches.[L6793,L6796,L6799,L6805,L6808,L6811] Sumatriptan is the first of the triptans and was made available in Europe in 1991 to treat migraines.[A179761] Sumatriptan was granted FDA approval on 28...

Categories: Agents that produce hypertension Amides Amines Analgesics Antidepressive Agents Antimigraine Preparations BCRP/ABCG2 Substrates Biogenic Amines Biogenic Monoamines Cardiovascular Agents Central Nervous System Depressants Drugs that are Mainly Renally Excreted Genito Urinary System and Sex Hormones Heterocyclic Compounds, Fused-Ring Indoles Monoamine Oxidase A Substrates Nervous System Neurotransmitter Agents OATP1B1/SLCO1B1 Substrates P-glycoprotein substrates Selective Serotonin 5-HT1 Receptor Agonists Selective Serotonin Agonists Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists Serotonin 5-HT1 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Serotonin-1b and Serotonin-1d Receptor Agonist Sulfonamides Sulfones Sulfur Compounds Triptans Tryptamines Vasoconstrictor Agents
Cross-references: BindingDB: 50005835 ChEBI: 10650 CHEMBL128 ChemSpider: 5165 Drugs Product Database (DPD): 11323 Guide to Pharmacology: 119 IUPHAR: 119 C07319 D00451 PharmGKB: PA451566 PubChem:5358 PubChem:46506520 RxCUI: 37418 Therapeutic Targets Database: DNC001649 Wikipedia: Sumatriptan ZINC: ZINC000000014360
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
P28221 HTR1D Homo sapiens Human PF00001 8.2 Ki ChEMBL;BindingDB
P28335 HTR2C Homo sapiens Human PF00001 8.1 IC50 ChEMBL;BindingDB
P46098 HTR3A Homo sapiens Human PF02931 PF02932 8.0 IC50 ChEMBL;BindingDB
P28222 HTR1B Homo sapiens Human PF00001 8.0 Ki ChEMBL;BindingDB
P30939 HTR1F Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 6.4 Ki ChEMBL;BindingDB
P08908 HTR1A Homo sapiens Human PF00001 6.4 Ki ChEMBL;BindingDB
P47898 HTR5A Homo sapiens Human PF00001 6.3 IC50 ChEMBL;BindingDB
P34969 HTR7 Homo sapiens Human PF00001 6.0 Ki ChEMBL;BindingDB
DrugBank Target Actions (9)
Target Gene Target Name Action Type
P21397 MAOA Amine oxidase [flavin-containing] A substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P28221 HTR1D 5-hydroxytryptamine receptor 1D agonist targets
P28222 HTR1B 5-hydroxytryptamine receptor 1B agonist targets
P30939 HTR1F 5-hydroxytryptamine receptor 1F agonist targets
P46721 P46721 Solute carrier organic anion transporter family member 1A2 inducer transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters
Q9UNQ0 ABCG2 Broad substrate specificity ATP-binding cassette transporter ABCG2 substrate transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 substrate transporters